Louis H. Miller

Q: What Schools Are Affiliated With Louis H. Miller

Louis H. Miller is affiliated with the following schools: Colorado State University, Stockholm University, George Washington University, Ehime University, Virginia Commonwealth University, Case Western Reserve University, Johns Hopkins University, University of Washington, University of Bamako, University of California, San Francisco, Columbia University

Louis H. Miller's AcademicInfluence.com Rankings

Louis H. Miller

Biology

#4350

World Rank

#6499

Historical Rank

#1640

USA Rank

Parasitology

World Rank

Historical Rank

USA Rank

biology Degrees

Download Badge

Biology

Why Is Louis H. Miller Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Louis H. Miller's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

International union of pharmacology. XXII. Nomenclature for chemokine receptors. (2000) (1929)
The pathogenic basis of malaria (2002) (1784)
The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. (1976) (1210)
Switches in expression of plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes (1995) (995)
P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1 (1997) (620)
Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. (1975) (609)
A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. (1993) (597)
Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite (1978) (573)
Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. (1994) (573)
Malaria biology and disease pathogenesis: insights for new treatments (2013) (511)
Genetic selection of a Plasmodium-refractory strain of the malaria vector Anopheles gambiae. (1986) (492)
CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. (1988) (473)
A family of erythrocyte binding proteins of malaria parasites. (1992) (463)
Identification of a strain-specific malarial antigen exposed on the surface of Plasmodium falciparum-infected erythrocytes (1984) (419)
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray (2010) (413)
Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion (1994) (401)
Invasion of erythrocytes by malaria merozoites. (1975) (400)
Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). (1993) (396)
A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains (1988) (386)
Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence (1985) (371)
Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51 (2008) (369)
Artemisinin: Discovery from the Chinese Herbal Garden (2011) (354)
Plasmodium falciparum malaria. Ultrastructure of parasitized erythrocytes in cardiac vessels. (1971) (351)
Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. (1983) (336)
Plasmodium Biology Genomic Gleanings (2003) (334)
Interaction between cytochalasin B-treated malarial parasites and erythrocytes. Attachment and junction formation (1979) (311)
The duffy receptor family of plasmodium knowlesi is located within the micronemes of invasive malaria merozoites (1990) (301)
Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. (2000) (300)
Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells. (1981) (287)
Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection. (1999) (277)
Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion (2011) (267)
In Vitro Studies with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response (2002) (264)
Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. (1988) (263)
Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. (1987) (260)
Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria (2005) (256)
Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. (2014) (250)
Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. (2004) (247)
Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. (1979) (233)
Correction for Smith et al., Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: A parasite adhesion trait implicated in cerebral malaria (2000) (231)
The Plasmodium falciparum-Specific Human Memory B Cell Compartment Expands Gradually with Repeated Malaria Infections (2010) (231)
Malaria parasite chitinase and penetration of the mosquito peritrophic membrane. (1991) (225)
Evidence for differences in erythrocyte surface receptors for the malarial parasites, Plasmodium falciparum and Plasmodium knowlesi (1977) (224)
Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. (2008) (222)
Evidence for a switching mechanism in the invasion of erythrocytes by Plasmodium falciparum. (1990) (217)
PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum (2013) (217)
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. (2005) (213)
Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes (1990) (208)
Immunogenicity and In Vivo Efficacy of Recombinant Plasmodium falciparum Merozoite Surface Protein-1 in Aotus Monkeys (1995) (203)
Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. (1985) (201)
Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effect (1997) (199)
Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. (2008) (198)
Vaccination of Monkeys with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 Confers Protection against Blood-Stage Malaria (2002) (197)
Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes. (1994) (192)
Characterization of a Plasmodium falciparum erythrocyte-binding protein paralogous to EBA-175 (2001) (186)
The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. (1987) (186)
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali. (2009) (180)
Stable integration and expression of a bacterial gene in the mosquito Anopheles gambiae. (1987) (178)
Pathways and strategies for developing a malaria blood-stage vaccine. (1998) (178)
Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes (1989) (177)
Malaria and the Red Cell (1982) (176)
Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1 (2009) (168)
The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes (1996) (168)
Research toward malaria vaccines. (1986) (167)
Falciparum malaria parasites invade erythrocytes that lack glycophorin A and B (MkMk). Strain differences indicate receptor heterogeneity and two pathways for invasion. (1987) (165)
Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum (1988) (165)
Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine (1986) (165)
Cloning of the Plasmodium vivax Duffy receptor. (1991) (164)
Evolutionary relatedness of Plasmodium species as determined by the structure of DNA. (1984) (162)
The discovery of artemisinin and the Nobel Prize in Physiology or Medicine (2015) (162)
Plasmodium gallinaceum: a refractory mechanism of ookinete killing in the mosquito, Anopheles gambiae. (1995) (158)
Advances and challenges in malaria vaccine development. (2010) (158)
Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. (2005) (155)
Receptor-like specificity of a Plasmodium knowlesi malarial protein that binds to Duffy antigen ligands on erythrocytes (1988) (153)
Plasmodium gallinaceum: differential killing of some mosquito stages of the parasite by insect defensin. (1998) (153)
The origin of parasitophorous vacuole membrane lipids in malaria-infected erythrocytes. (1993) (151)
Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. (1996) (151)
Splenic requirement for antigenic variation and expression of the variant antigen on the erythrocyte membrane in cloned Plasmodium knowlesi malaria (1983) (150)
Immunity to Recombinant Plasmodium falciparum Merozoite Surface Protein 1 (MSP1): Protection in Aotus nancymai Monkeys Strongly Correlates with Anti-MSP1 Antibody Titer and In Vitro Parasite-Inhibitory Activity (2006) (150)
Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate* (2009) (148)
Plasmodium falciparum strain-specific antibody blocks binding of infected erythrocytes to amelanotic melanoma cells (1983) (147)
Plasmodium falciparum malaria: association of knobs on the surface of infected erythrocytes with a histidine-rich protein and the erythrocyte skeleton (1984) (146)
Malaria transmission-blocking vaccines—how can their development be supported? (2000) (146)
Distribution of mature trophozoites and schizonts of Plasmodium falciparum in the organs of Aotus trivirgatus, the night monkey. (1969) (144)
Malaria (Plasmodium knowlesi) merozoites: immunity and the surface coat. (1975) (139)
A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium. (1990) (138)
Pathogenesis of infectious diseases of fish. (1986) (137)
Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans. (1994) (133)
Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion. (1981) (132)
Protein Antigenic Structures Recognized by T Cells; Potential Applications to Vaccine Design (1987) (132)
The Journey of Malaria Sporozoites in the Mosquito Salivary Gland (1994) (131)
Analysis of adhesive domains from the A4VAR Plasmodium falciparum erythrocyte membrane protein-1 identifies a CD36 binding domain. (1998) (129)
Mapping of the Region of Complement Receptor (CR) 1 Required for Plasmodium falciparum Rosetting and Demonstration of the Importance of CR1 in Rosetting in Field Isolates1 (2000) (129)
Freeze-fracture study on the erythrocyte membrane during malarial parasite invasion (1981) (127)
Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria. (2008) (126)
Plasmodium knowlesi: studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors. (1983) (126)
Gametocytogenesis by malaria parasites in continuous culture (1980) (125)
Efficacy of Two Alternate Vaccines Based on Plasmodium falciparum Merozoite Surface Protein 1 in anAotus Challenge Trial (2001) (124)
Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex (2006) (124)
Alteration in the rheologic properties of Plasmodium knowlesi--infected red cells. A possible mechanism for capillary obstruction. (1971) (124)
Isolation of multiple sequences from the Plasmodium falciparum genome that encode conserved domains homologous to those in erythrocyte-binding proteins. (1995) (121)
Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites. (2004) (118)
Research toward vaccines against malaria (1998) (118)
Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria (2008) (117)
Polymorphism in a Plasmodium falciparum Erythrocyte-binding Ligand Changes Its Receptor Specificity (2002) (116)
Invasion of erythrocytes by Plasmodium falciparum malaria parasites: evidence for receptor heterogeneity and two receptors (1986) (112)
Malaria pathogenesis. (1994) (110)
Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A (2008) (109)
Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes. (1983) (107)
Plasmodium falciparum: effect of time in continuous culture on binding to human endothelial cells and amelanotic melanoma cells. (1983) (105)
Pf155/RESA antigen is localized in dense granules of Plasmodium falciparum merozoites. (1990) (104)
Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria. (2014) (104)
A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum (2001) (103)
Limited immunological recognition of critical malaria vaccine candidate antigens. (1988) (103)
Polymorphism in the Plasmodium falciparum erythrocyte-binding ligand JESEBL/EBA-181 alters its receptor specificity. (2004) (102)
The peritrophic membrane as a barrier: its penetration by Plasmodium gallinaceum and the effect of a monoclonal antibody to ookinetes. (1991) (102)
Caveola--vesicle complexes in the plasmalemma of erythrocytes infected by Plasmodium vivax and P cynomolgi. Unique structures related to Schüffner's dots. (1975) (101)
The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development. (1988) (100)
Recent advances in recombinant protein-based malaria vaccines (2015) (96)
Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: Implications for vaccine design (2008) (95)
Plasmodium falciparum malaria. An amelanotic melanoma cell line bears receptors for the knob ligand on infected erythrocytes. (1982) (94)
The Duffy Blood Group Determinants: Their Role in the Susceptibility of Human and Animal Erythrocytes to Plasmodium knowlesi Malaria (1977) (94)
World Malaria Day 2009: What Malaria Knows about the Immune System That Immunologists Still Do Not (2009) (92)
Interdependence of CD4+ T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development. (1989) (91)
Recombinant Plasmodium falciparum reticulocyte homology protein 4 binds to erythrocytes and blocks invasion (2007) (91)
Domain III of Plasmodium falciparum apical membrane antigen 1 binds to the erythrocyte membrane protein Kx. (2005) (88)
Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys. (2002) (88)
Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line (2002) (87)
Release of merozoite dense granules during erythrocyte invasion by Plasmodium knowlesi (1989) (87)
A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults. (2009) (86)
The TLR9 Ligand CpG Promotes the Acquisition of Plasmodium falciparum-Specific Memory B Cells in Malaria-Naive Individuals1 (2009) (86)
Disrupting malaria parasite AMA1 – RON2 interaction with a small molecule prevents erythrocyte invasion (2013) (86)
Developmentally regulated infectivity of malaria sporozoites for mosquito salivary glands and the vertebrate host (1992) (85)
Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris. (2006) (85)
Immunity to sexual stages of malaria parasites. (1988) (84)
Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP142-C1/Alhydrogel with and without CPG 7909 in Malaria Naïve Adults (2010) (83)
Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates. (2007) (82)
Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25 (2007) (82)
Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated form (1992) (82)
Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. (1996) (81)
Monoclonal antibody characterization of Plasmodium falciparum antigens. (1984) (81)
In Vitro Growth-Inhibitory Activity and Malaria Risk in a Cohort Study in Mali (2009) (80)
Biochemical and Immunological Characterization of Bacterially Expressed and Refolded Plasmodium falciparum 42-Kilodalton C-Terminal Merozoite Surface Protein 1 (2003) (80)
Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting Plasmodium falciparum Growth, as Determined by the In Vitro Growth Inhibition Assay (2009) (80)
Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. (2001) (80)
Progress in the development of recombinant and synthetic blood-stage malaria vaccines (2003) (80)
Invasion of erythrocytes by Plasmodium falciparum malaria parasites: evidence for receptor heterogeneity and two receptors. (1986) (79)
CD36 peptides that block cytoadherence define the CD36 binding region for Plasmodium falciparum-infected erythrocytes. (1999) (79)
Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria (2014) (79)
Genetic control of immunity to Plasmodium yoelii sporozoites. (1989) (79)
Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1. (1999) (79)
Factors affecting the ability of isolated Plasmodium knowlesi merozoites to attach to and invade erythrocytes (1980) (79)
NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity (2018) (78)
Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax. (1985) (78)
Altered expression of Plasmodium knowlesi variant antigen on the erythrocyte membrane in splenectomized rhesus monkeys. (1982) (78)
Immunity to Blood Parasites of Animals and Man (1977) (78)
Anti-gamete monoclonal antibodies synergistically block transmission of malaria by preventing fertilization in the mosquito. (1980) (77)
Staurosporine inhibits invasion of erythrocytes by malarial merozoites. (1994) (77)
Upregulation of expression of the reticulocyte homology gene 4 in the Plasmodium falciparum clone Dd2 is associated with a switch in the erythrocyte invasion pathway. (2006) (76)
Phase 1 Study of Two Merozoite Surface Protein 1 (MSP142) Vaccines for Plasmodium falciparum Malaria (2007) (74)
Epigenetic control of the variable expression of a Plasmodium falciparum receptor protein for erythrocyte invasion (2010) (74)
The Plasmodium falciparum rhoptry protein RhopH3 plays essential roles in host cell invasion and nutrient uptake (2017) (74)
INFLUENCE OF ERYTHROCYTE MEMBRANE COMPONENTS ON MALARIA MEROZOITE INVASION (1973) (72)
Identification of an erythrocyte component carrying the Duffy blood group Fya antigen. (1984) (72)
Processing of a major parasite surface glycoprotein during the ultimate stages of differentiation in Plasmodium knowlesi. (1984) (71)
The glycophorin C N-linked glycan is a critical component of the ligand for the Plasmodium falciparum erythrocyte receptor BAEBL (2006) (70)
Structure of the Plasmodium 6-cysteine s48/45 domain (2012) (69)
Sporogonic development of a malaria parasite in vitro. (1992) (69)
Invasion of erythrocytes by malaria merozoites. (1979) (68)
Deep vascular schizogony of Plasmodium knowlesi in Macaca mulatta. Distribution in organs and ultrastructure of parasitized red cells. (1971) (68)
Plasmodium gallinaceum: sporozoite invasion of Aedes aegypti salivary glands is inhibited by anti-gland antibodies and by lectins. (1995) (67)
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals. (2009) (67)
Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians (2007) (67)
Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity (2011) (67)
Influence of the spleen on the expression of surface antigens on parasitized erythrocytes. (1983) (66)
The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation. (1988) (66)
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine (2010) (65)
Comparison of Biological Activity of Human Anti-Apical Membrane Antigen-1 Antibodies Induced by Natural Infection and Vaccination1 (2008) (65)
Aotus New World monkeys: model for studying malaria-induced anemia. (2002) (65)
Frequency of blood group antigens in Nigerian children with falciparum malaria. (1979) (64)
Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine (2011) (64)
Plasmodium falciparum gene encoding a protein similar to the 78-kDa rat glucose-regulated stress protein. (1988) (64)
Structural and Biochemical Characterization of Plasmodium falciparum 12 (Pf12) Reveals a Unique Interdomain Organization and the Potential for an Antiparallel Arrangement with Pf41* (2013) (64)
Molecular basis for the dichotomy in Plasmodium falciparum adhesion to CD36 and chondroitin sulfate A (2002) (63)
Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans (2016) (63)
The major merozoite surface protein as a malaria vaccine target. (1993) (63)
Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice (2010) (63)
Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria. (1990) (63)
Mononeme: A new secretory organelle in Plasmodium falciparum merozoites identified by localization of rhomboid-1 protease (2007) (62)
Trafficking of Plasmodium chabaudi adami-infected erythrocytes within the mouse spleen. (1996) (62)
Resistance of Melanesian elliptocytes (ovalocytes) to invasion by Plasmodium knowlesi and Plasmodium falciparum malaria parasites in vitro. (1983) (61)
Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation? (2018) (60)
Target antigens in malaria transmission blocking immunity. (1984) (60)
Rodent blood-stage Plasmodium survive in dendritic cells that infect naive mice (2011) (60)
Two worlds of malaria. (2003) (60)
Erythrocyte receptors for malaria merozoites. (1977) (60)
The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes (2001) (58)
Targeting glutamine metabolism rescues mice from late-stage cerebral malaria (2015) (58)
Identification of complement receptor one (CR1) polymorphisms in West Africa (2000) (58)
Studies on the role of red blood cell glycoproteins as receptors for invasion by Plasmodium falciparum merozoites. (1982) (57)
Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2. (1988) (57)
A Robust Neutralization Test for Plasmodium falciparum Malaria (2001) (57)
Decreased deformability of Plasmodium coatneyi-infected red cells and its possible relation to cerebral malaria. (1972) (56)
Evaluation of clindamycin in combination with quinine against multidrug-resistant strains of Plasmodium falciparum. (1974) (56)
The Cysteine-Rich Interdomain Region from the Highly Variable Plasmodium falciparum Erythrocyte Membrane Protein-1 Exhibits a Conserved Structure (2008) (56)
Comparison of the primary structure of the 25 kDa ookinete surface antigens of Plasmodium falciparum and Plasmodium gallinaceum reveal six conserved regions. (1989) (55)
SEVERE MALARIA AND GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY: A REAPPRAISAL OF THE MALARIA/G-6-P.D. HYPOTHESIS (1979) (55)
Immunization of monkeys with a 140 kilodalton merozoite surface protein of Plasmodium knowlesi malaria: appearance of alternate forms of this protein. (1985) (55)
The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali. (2009) (54)
Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens. (1989) (54)
Structural alteration of the membrane of erythrocytes infected with Babesia bovis. (1985) (54)
Human T clones reactive to the sexual stages of Plasmodium falciparum malaria. High frequency of gamete-reactive T cells in peripheral blood from nonexposed donors. (1987) (54)
Electron microscopy of knobs in Plasmodium falciparum-infected erythrocytes. (1983) (54)
Innate resistance in malaria (1976) (54)
PfCDPK1 is critical for malaria parasite gametogenesis and mosquito infection (2018) (53)
Structural alteration of the erythrocyte membrane during malarial parasite invasion and intraerythrocytic development. (1983) (53)
Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. Paucity of clones responsive to intact parasites. (1994) (52)
The IC(50) of anti-Pfs25 antibody in membrane-feeding assay varies among species. (2010) (52)
Failure of chloroquine in human babesiosis (Babesia microti): case report and chemotherapeutic trials in hamsters. (1978) (52)
CD8+ T cells target cerebrovasculature in children with cerebral malaria. (2019) (51)
The challenge of malaria. (1992) (51)
Modifications in the CD36 binding domain of the Plasmodium falciparum variant antigen are responsible for the inability of chondroitin sulfate A adherent parasites to bind CD36. (2001) (51)
Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children (2008) (51)
Penetration of the mosquito (Aedes aegypti) midgut wall by the ookinetes of Plasmodium gallinaceum. (1992) (50)
Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii (1997) (50)
Disruption of the C-terminal region of EBA-175 in the Dd2/Nm clone of Plasmodium falciparum does not affect erythrocyte invasion. (2000) (50)
B cell analysis of ethnic groups in Mali with differential susceptibility to malaria (2012) (50)
Phase 1 Study in Malaria Naïve Adults of BSAM2/Alhydrogel®+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria (2012) (49)
Perspectives on malaria vaccine development. (1996) (49)
Monoclonal antibodies to a 140,000-m.w. protein on Plasmodium knowlesi merozoites inhibit their invasion of rhesus erythrocytes. (1984) (48)
Intranasal immunization with yeast‐expressed 19 kD carboxyl‐terminal fragment of Plasmodium yoelii merozoite surface protein‐1 (yMSP119) induces protective immunity to blood stage malaria infection in mice (1998) (48)
The sites of deep vascular schizogony in Plasmodium coatneyi malaria. (1969) (48)
The etiology of severe anemia in a village and a periurban area in Mali. (2004) (46)
Plasmodium gallinaceum: antibodies to circumsporozoite protein prevent sporozoites from invading the salivary glands of Aedes aegypti. (1992) (46)
Toll-like receptor 9 antagonizes antibody affinity maturation (2018) (45)
Identification of a 67‐amino‐acid region of the Plasmodium falciparum variant surface antigen that binds chondroitin sulphate A and elicits antibodies reactive with the surface of placental isolates (2004) (45)
Induction of transmission-blocking immunity in Aotus monkeys by vaccination with a Plasmodium vivax clinical grade PVS25 recombinant protein. (2005) (45)
Plasmodium vivax Infections over 3 Years in Duffy Blood Group Negative Malians in Bandiagara, Mali. (2017) (45)
Parasite polymorphism present within minimal T cell epitopes of Plasmodium falciparum circumsporozoite protein. (1988) (45)
A comparison of knobby (K+) and knobless (K-) parasites from two strains of Plasmodium falciparum. (1983) (44)
Plasmodium knowlesi: functional immunity and antimerozoite antibodies in rhesus monkeys after repeated infection. (1977) (43)
Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensity. (2007) (43)
Inhibiting the Mammalian Target of Rapamycin Blocks the Development of Experimental Cerebral Malaria (2015) (42)
Are trials in New World monkeys on the critical path for blood-stage malaria vaccine development? (2001) (42)
Lack of cross-reactivity between variant T cell determinants from malaria circumsporozoite protein. (1988) (42)
A 60-kDa Plasmodium falciparum protein at the moving junction formed between merozoite and erythrocyte during invasion. (1989) (41)
Overcoming Allelic Specificity by Immunization with Five Allelic Forms of Plasmodium falciparum Apical Membrane Antigen 1 (2013) (41)
The Duffy blood group and resistance to Plasmodium vivax in Honduras. (1978) (41)
A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection (2017) (41)
In Immunization with Plasmodium falciparum Apical Membrane Antigen 1, the Specificity of Antibodies Depends on the Species Immunized (2007) (41)
Critical stages in the development of Plasmodium in mosquitoes. (1991) (41)
Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP119) and their role in immunity to malaria (1998) (40)
Cytoadherence of Plasmodium falciparum-infected erythrocytes to human melanoma cell lines correlates with surface OKM5 antigen (1987) (40)
Vaccination-induced variation in the 140 kD merozoite surface antigen of Plasmodium knowlesi malaria (1987) (40)
Plasmodium falciparum Is Able To InvadeErythrocytes through a Trypsin-Resistant Pathway Independent ofGlycophorinB (2003) (39)
Malaria--a Shadow over Africa (2002) (38)
Posttranslational Modification of Recombinant Plasmodium falciparum Apical Membrane Antigen 1: Impact on Functional Immune Responses to a Malaria Vaccine Candidate (2005) (38)
Plasmodium gallinaceum: induction of male gametocyte exflagellation by phosphodiesterase inhibitors. (1978) (37)
A monoclonal antibody to rhesus erythrocyte band 3 inhibits invasion by malaria (Plasmodium knowlesi) merozoites. (1983) (37)
Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults. (2010) (37)
Hyponatraemia in malaria. (1967) (37)
The ultrastructure of red cells infected by Plasmodium falciparum in man. (1972) (37)
Identification of surface proteins on viable Plasmodium knowlesi merozoites. (1981) (36)
Ethnic differences in susceptibility to malaria: what have we learned from immuno-epidemiological studies in West Africa? (2015) (36)
Permeability of intact and dechorionated eggs of the Anopheles mosquito to water vapor and liquid water: a comparison with Drosophila. (1996) (36)
Use of o-phthalaldehyde assay to determine protein contents of Alhydrogel-based vaccines. (2009) (36)
Plasmodium falciparum Calcium-Dependent Protein Kinase 2 Is Critical for Male Gametocyte Exflagellation but Not Essential for Asexual Proliferation (2017) (36)
A high malaria reinfection rate in children and young adults living under a low entomological inoculation rate in a periurban area of Bamako, Mali. (2002) (36)
Hypothesis on the mechanism of erythrocyte invasion by malaria merozoites. (1977) (36)
Ex Vivo Cytokine and Memory T Cell Responses to the 42-kDa Fragment of Plasmodium falciparum Merozoite Surface Protein-1 in Vaccinated Volunteers1 (2008) (35)
Development of a Direct Alhydrogel Formulation Immunoassay (DAFIA). (2009) (35)
The Duffy blood group phenotype in American blacks infected with Plasmodium vivax in Vietnam. (1978) (35)
Acute renal failure in Plasmodium falciparum malaria. Treatment of peritoneal dialysis. (1968) (35)
Reduced Activity of Mutant Calcium-Dependent Protein Kinase 1 Is Compensated in Plasmodium falciparum through the Action of Protein Kinase G (2016) (35)
Spleen function in quartan malaria (due to Plasmodium inui): evidence for both protective and suppressive roles in host defense. (1977) (34)
Deep vascular schizogony in Plasmodium fragile: organ distribution and ultrastructure of erythrocytes adherent to vascular endothelium. (1975) (34)
Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders. (2008) (34)
Revisiting Freund's incomplete adjuvant for vaccines in the developing world. (2005) (33)
Cellular mechanisms in immunity to blood stage infection. (1990) (33)
A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates (2009) (32)
Invasion of erythrocytes by malaria parasites: erythrocyte ligands and parasite receptors. (1988) (32)
Analysis of the Conformation and Function of the Plasmodium falciparum Merozoite Proteins MTRAP and PTRAMP (2012) (32)
An in vitro assay for sequestration: binding of Plasmodium falciparum-infected erythrocytes to formalin-fixed endothelial cells and amelanotic melanoma cells. (1985) (31)
From Tucson to Genomics and Transgenics: The Vector Biology Network and the Emergence of Modern Vector Biology (2009) (31)
Molecular basis of binding of the Plasmodium falciparum receptor BAEBL to erythrocyte receptor glycophorin C. (2009) (31)
Biolistic techniques for transfection of mosquito embryos (Anopheles gambiae). (1994) (31)
Localization of the major Plasmodium falciparum glycoprotein on the surface of mature intraerythrocytic trophozoites and schizonts. (1984) (31)
Induction of crossreactive antibodies against the Plasmodium falciparum variant protein (2003) (30)
Plasmodium falciparum malaria: cytoadherence of infected erythrocytes to endothelial cells and associated changes in the erythrocyte membrane. (1984) (30)
Factors influencing invasion of erythrocytes by Plasmodium falciparum parasites: the effects of an N-acetyl glucosamine neoglycoprotein and an anti-glycophorin A antibody. (1986) (30)
Identification of Plasmodium knowlesi erythrocyte binding proteins. (1988) (30)
An electron microscopical study of the interaction of monoclonal antibodies with gametes of the malarial parasite Plasmodium gallinaceum. (1981) (30)
Involvement of T cells in malaria immunity: implications for vaccine development. (1989) (30)
Determinants on surface proteins of Plasmodium knowlesi merozoites common to Plasmodium falciparum schizonts (1980) (30)
Studies of the receptors on melanoma cells for Plasmodium falciparum infected erythrocytes. (1989) (29)
Permeabilization of eggs of the malaria mosquito Anopheles gambiae. (1996) (29)
Invasion of mouse erythrocytes by the human malaria parasite, Plasmodium falciparum (1987) (29)
The malaria merozoite surface: a 140,000 m.w. protein antigenically unrelated to other surface components on Plasmodium knowlesi merozoites. (1983) (28)
Movement of a falciparum malaria protein through the erythrocyte cytoplasm to the erythrocyte membrane is associated with lysis of the erythrocyte and release of gametes (1989) (28)
Ultrastructural changes of the erythrocyte membrane in ovale-type malarial parasites. (1977) (27)
DNA Immunization with the Cysteine-Rich Interdomain Region 1 of the Plasmodium falciparum Variant Antigen Elicits Limited Cross-Reactive Antibody Responses (2003) (27)
Motherhood and malaria (1998) (27)
Molecular basis for mutation in a surface protein expressed by malaria parasites. (1988) (27)
Malaria parasite detection and cell counting for human and mouse using thin blood smear microscopy (2018) (27)
The immunologic significance of variation within malaria circumsporozoite protein sequences. (1989) (27)
The spirit of Dakar: a call for action on malaria (1997) (26)
Blocking of the receptor-mediated invasion of erythrocytes by Plasmodium knowlesi malaria with sulfated polysaccharides and glycosaminoglycans. (1991) (26)
Cellular mechanisms in the immune response to malaria in Plasmodium vinckei-infected mice (1995) (26)
Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection. (2006) (25)
Improved yield of recombinant merozoite Surface protein 3 (MSP3) from Pichia pastoris using chemically defined media. (2005) (25)
Enhanced antibody responses to Plasmodium falciparum Pfs28 induced in mice by conjugation to ExoProtein A of Pseudomonas aeruginosa with an improved procedure. (2009) (25)
Thrombospondin binding by parasitized erythrocyte isolates in falciparum malaria. (1987) (25)
Definition of the minimal domain of CIDR1alpha of Plasmodium falciparum PfEMP1 for binding CD36. (2002) (25)
Molecular characterization of Plasmodium falciparum S-adenosylmethionine synthetase. (1999) (25)
Human and murine CD4 T cell epitopes map to the same region of the malaria circumsporozoite protein: limited immunogenicity of sporozoites and circumsporozoite protein. (1988) (25)
Comparative studies on the pathology and host physiology of malarias. I. Plasmodium coatneyi. (1967) (24)
Plasmodium falciparum merozoite surface protein 1 blocks the proinflammatory protein S100P (2012) (24)
Infected erythrocytes expressing DC13 PfEMP1 differ from recombinant proteins in EPCR-binding function (2018) (24)
N-acetylneuraminic acid deficiency in erythrocyte membranes: biophysical and biochemical correlates. (1974) (24)
Plasmodium vivax: transmission-blocking immunity in a malaria-endemic area of Colombia. (2005) (24)
Perspectives for malaria vaccination. (1984) (23)
Immunity to malarial antigens on the surface of Plasmodium falciparum-infected erythrocytes. (1983) (23)
Comparing the understanding of subjects receiving a candidate malaria vaccine in the United States and Mali. (2010) (23)
Structural alteration of the membrane of erythrocytes infected with Plasmodium falciparum. (1985) (23)
Density distribution of red cells infected by Plasmodium knowlesi and plasmodium coatneyi. (1971) (22)
Polymorphism in the circumsporozoite (CS) protein of Plasmodium falciparum. (1989) (22)
Plasmodium falciparum: a high proportion of parasites from a population of the Dd2 strain are able to invade erythrocytes by an alternative pathway. (1997) (22)
Identification of VAR2CSA Domain-Specific Inhibitory Antibodies of the Plasmodium falciparum Erythrocyte Membrane Protein 1 Using a Novel Flow Cytometry Assay (2013) (22)
Binding of Aldolase and Glyceraldehyde-3-Phosphate Dehydrogenase to the Cytoplasmic Tails of Plasmodium falciparum Merozoite Duffy Binding-Like and Reticulocyte Homology Ligands (2012) (22)
Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structure. (2009) (21)
Plasmodium gallinaceum: differential lysis of two developmental stages of malaria sporozoites by the alternative pathway of complement. (1994) (21)
Plasmodium falciparum: elicitation by peptides and recombinant circumsporozoite proteins of circulating mouse antibodies inhibiting sporozoite invasion of hepatoma cells. (1987) (21)
Malaria: A sporozoite runs through it (2001) (21)
A perspective on malaria vaccines. (1980) (20)
Plasmodium falciparum: characterization of a late asexual stage golgi protein containing both ankyrin and DHHC domains. (2005) (20)
Difference in surface charge between host cells and malarial parasites. (1973) (19)
Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer. (2012) (19)
Desperately Seeking Therapies for Cerebral Malaria (2020) (19)
Plasmodium falciparum protein associated with the invasion junction contains a conserved oxidoreductase domain (1995) (19)
Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen status (2016) (19)
Identification of a cryptic intron in the Plasmodium vivax Duffy binding protein gene. (1992) (19)
Current prospects and problems for a malaria vaccine. (1977) (19)
Recognition of red cells by malaria parasites: the role of erythrocyte-binding proteins. (1991) (19)
Vaccines against the blood stages of falciparum malaria. (1998) (19)
Comparative studies on the pathology and host physiology of malarias. II. Gibbon malaria. (1967) (19)
Longitudinal analysis of naturally acquired PfEMP1 CIDR domain variant antibodies identifies associations with malaria protection. (2020) (19)
MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice (2018) (19)
Immunogenicity of Self-Associated Aggregates and Chemically Cross-Linked Conjugates of the 42 kDa Plasmodium falciparum Merozoite Surface Protein-1 (2012) (18)
A Way Forward for Culturing Plasmodium vivax. (2020) (18)
Transcriptome profiling of Plasmodium vivax in Saimiri monkeys identifies potential ligands for invasion (2019) (18)
Rhesus monkeys protected against Plasmodium knowlesi malaria produce antibodies against a 65,000-MrP. knowlesi glycoprotein at the surface of infected erythrocytes (1981) (18)
Plasmodium falciparum: invasion of Aotus monkey red blood cells and adaptation to Aotus monkeys. (1999) (17)
Method for in situ hybridization to polytene chromosomes from ovarian nurse cells of Anopheles gambiae (Diptera: Culicidae). (1990) (17)
The need for assays predictive of protection in development of malaria bloodstage vaccines. (1997) (17)
Deletion of Plasmodium falciparum Protein RON3 Affects the Functional Translocation of Exported Proteins and Glucose Uptake (2019) (16)
Protective selective pressure (1996) (16)
Frequent expansion of Plasmodium vivax Duffy Binding Protein in Ethiopia and its epidemiological significance (2019) (16)
The serologic diagnosis of parasitic infections in medical practice. (1969) (16)
Sensitivity of four Central American strains of Plasmodium vivax to primaquine. (1974) (15)
Whole genome sequencing of Plasmodium vivax isolates reveals frequent sequence and structural polymorphisms in erythrocyte binding genes (2020) (15)
Localization of protective 143/140 kDa antigens of Plasmodium knowlesi by the use of antibodies and ultracryomicrotomy. (1986) (14)
The Plasmodium falciparum rhoptry bulb protein RAMA plays an essential role in rhoptry neck morphogenesis and host red blood cell invasion (2019) (14)
Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations (2020) (14)
A review. Innate resistance in malaria. (1976) (14)
Effective vaccine for humans? (1988) (14)
Duffy phenotypes in Malaysian populations: correction of previous unusual findings. (1988) (14)
LOW ERYTHROCYTE PYRIDOXAL- KINASE ACTIVITY IN BLACKS: ITS POSSIBLE RELATION TO FALCIPARUM MALARIA (1978) (14)
Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay (2011) (13)
Selection of increased quinine resistance in Plasmodium falciparum in Aotus monkeys. (1978) (13)
The Need for New Approaches to Antimalarial Chemotherapy (2001) (13)
Plasmodium gallinaceum: avian screen for drugs with radical curative properties. (1983) (12)
Search for the Sialic Acid–Independent Receptor on Red Blood Cells for Invasion by Plasmodium falciparum (1999) (12)
A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy (1995) (12)
Immunological responses against Plasmodium falciparum Apical Membrane Antigen 1 vaccines vary depending on the population immunized. (2011) (12)
Genetically determined human resistance factors. (1988) (12)
Falciparum malaria parasitized erythrocytes bind to a carboxy-terminal thrombospondin fragment and not the amino-terminal heparin-binding region. (1990) (12)
The sorozoite, the merozoite, and the infected red cell: Parasite ligands and host receptors (1999) (12)
Long term stability of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Montanide(®) ISA 720 and stabilized with glycine. (2011) (12)
T-cell antigens and epitopes in malaria vaccine design. (1990) (12)
Plasmodium vivax Infections Detected in a Large Number of Febrile Duffy-Negative Africans in Dschang, Cameroon. (2021) (11)
Plasmodium berghei: renal function and pathology in mice. (1968) (11)
PROPANOIC ACID-FERRIC OXIDE HYDROSOLS DIFFERENTIAL CELL SURFACE BINDING AND ITS RELATION TO MEMBRANE LIPID (1974) (11)
Plasmodium falciparum: effect of infected erythrocytes on clotting time of plasma. (1987) (11)
Immunogenic antigens common to Plasmodium knowlesi and Plasmodium falciparum are expressed on the surface of infected erythrocytes. (1982) (11)
The sites of deep vascular schizogony in chloroquine-resistant Plasmodium berghei in mice. (1969) (11)
Do we know enough to find an adjunctive therapy for cerebral malaria in African children? (2017) (10)
Research in malaria vaccines. (1986) (10)
The main obstacle to a malaria vaccine: the malaria parasite. (1988) (10)
Immunization of mice against Plasmodium vinckei with a combination of attenuated Salmonella typhimurium and malarial antigen (1990) (10)
Comparative studies on the pathology and host physiology of malarias. V. Hypovolaemia in Plasmodium coatneyi malaria. (1968) (10)
Invasion of erythrocytes by malaria merozoites: evidence for specific receptors involved in attachment and entry. (1981) (10)
Transmission of three strains of Plasmodium falciparum from monkey to man. (1973) (9)
A CTL epitope on the circumsporozoite protein of P. yoelii. (1990) (9)
Effects of macro molecules on the rheology and ultrastructure of red cell suspensions (1971) (8)
Evolution of the human genome under selective pressure from malaria: applications for control. (1999) (8)
An Impossible Journey? The Development of Plasmodium falciparum NF54 in Culex quinquefasciatus (2013) (8)
Expression of Heterologous Promoters in Lutzomyia longipalpis and Phlebotomus papatasi (Diptera: Psychodidae) Cell Lines (2000) (8)
Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25. (1995) (8)
A single-nucleotide polymorphism in a Plasmodium berghei ApiAP2 transcription factor alters the development of host immunity (2020) (8)
Interpreting challenge data from early phase malaria blood stage vaccine trials (2018) (8)
Phase 1 safety and immunogenicity trial of blood-stage malaria vaccines MSP1(42)-C1/alhydrogel with and without the addition of CPG 7909 in US adults (2007) (8)
Development of a Malaria T‐Cell Vaccine for Blood Stage Immunity (1992) (8)
The genetics and expression of an esterase locus inAnopheles gambiae (2004) (8)
Infected erythrocyte binding to hyaluronic acid and malaria in pregnant women. (2004) (8)
Comparative studies on the pathology and host physiology of malarias. VI. Plasmodium inui. (1968) (8)
Surface charge on plasmodium knowlesi and P. coatneyi-infected red cells of Macaca mulatta. (1972) (8)
Effects of heat shock on the survival of transgenic Anopheles gambiae (Diptera: Culicidae) under antibiotic selection. (1992) (8)
Phase 1 Study of Two Merozoite Surface Protein 1 ( MSP 142 ) Vaccines for Plasmodium falciparum Malaria (2007) (7)
Perspective on malaria eradication: is eradication possible without modifying the mosquito? (2009) (7)
Further evidence for the parasitic origin of the surface coat on Malaria merozoites. (1977) (7)
An evaluation of malaria fluorescent antibody patterns in several remote island populations of the New Hebrides, Solomons, Western Carolines, and New Guinea. (1976) (7)
Sequestration of schizonts of Plasmodium coatneyi in adipose tissue. (1970) (7)
Wr (a + b -) RED BLOOD CELLS ARE FULLY SUSCEPTIBLE TO INVASION BY PLASMODIUM FALCIPARUM (1984) (7)
Labeling of sporozoites of Plasmodium berghei with tritiated purines. (1974) (6)
Determination of protein concentration for protein-protein conjugates using ultraviolet absorption. (2013) (6)
Plasmodium berghei: uptake of clindamycin and its metabolites by mouse erythrocytes with clindamycin-sensitive and clindamycin-resistant parasites. (1979) (6)
Response to treatment in man of multi-drug resistant Plasmodium falciparum from Panama. (1974) (5)
T-cell antigenic sites of the malaria circumsporozoite protein (1989) (5)
Complement C1s cleaves PfEMP1 at interdomain conserved sites inhibiting Plasmodium falciparum cytoadherence (2021) (5)
Binding of infected red cells (1989) (5)
T-cell antigenic sites of the malaria circumsporozoite protein. (1989) (5)
Malaria Vaccine Development (2010) (5)
Plasmodium falciparum protein associated with the invasion junction contains a conserved oxidoreductase domain. (1995) (5)
Parasitized erythrocyte antigens and thrombospondin adhesion in the immunology and pathogenesis of falciparum malaria. (1986) (5)
MALARIAL A NTIGEN E XPOSED O N T HE SURFACE O F PLASMODIUM FALCIPARUM-INFEC TED ERYTHROCYTES (1984) (5)
Modifications in the CD 36 binding domain of the Plasmodium falciparum variant antigen are responsible for the inability of chondroitin sulfate A adherent parasites to bind CD 36 (2001) (5)
Comparative studies on the pathology and host physiology of malarias. 3. Plasma free fatty acids in normal and malarious gibbons (Hylobates lar). (1967) (4)
Genetic restriction of protective immunity to Plasmodium yoelii sporozoites. (1990) (4)
Selection of genetic variants from Plasmodium clones. (1991) (4)
Strategies for Malaria Control: Realities, Magic, and Science (1989) (4)
Immunity to protozoa. (1990) (4)
The genetics and expression of an esterase locus inAnopheles gambiae (1988) (4)
Testing the impact of a single nucleotide polymorphism in a Plasmodium berghei ApiAP2 transcription factor on experimental cerebral malaria in mice (2020) (4)
Meeting on Parasites and the invertebrate vector. John D and Catherine T MacArthur Foundation, November 18-21, 1993. (1994) (3)
Malaria. Effective vaccine for humans? (1988) (3)
Malaria. Protective selective pressure. (1996) (3)
An approach to development of specific T-lymphocyte lines by use of preprocessed antigens in Plasmodium vinckei vinckei murine malaria (1993) (3)
Visualization of red cell membranes of lysed malaria-infected cells by differential interference microscopy. (1973) (3)
Evidence for Receptor Heterogeneity and Two Receptors (2016) (3)
Letter: Transfusion malaria and immigrant blood donors. (1976) (3)
Purified IGGS from unvaccinated malians interfere with the biological activity of apical membrane antigen 1-specific IGGS as judged by the in vitro growth inhibition assay (2007) (3)
Chemical Genetics to Study Plasmodium Kinases (2016) (3)
Repeat region of plasmodium falciparum circumsporozoite protein does not recognize or bind to human hepatoma target cell (1986) (3)
Malaria: Protein-export pathway illuminated (2014) (3)
Meeting on Parasites and Invertebrate Vector (1994) (3)
Introduction to the Symposium on Cytoadherence and Cerebral Malaria (1990) (2)
Evidence implicating MHC genes in the immunological nonresponsiveness to the Plasmodium falciparum CS protein. (1990) (2)
Characterization of AMA1‐RON2L complex with native gel electrophoresis and capillary isoelectric focusing (2021) (2)
Renal pathology in acute malaria: a biopsy study. (1969) (2)
Author response: NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity (2018) (2)
Structural and Biochemical Characterization of Plasmodium falciparum 12 (Pf12) Reveals a Unique Interdomain Organization and the Potential for an Antiparallel (2013) (2)
Target antigens of malaria transmission blocking immunity. (1987) (2)
A critique of merozoite and sporozoite vaccines in malaria. (1977) (2)
Wright (a+b−) human erythrocytes and plasmodium falciparum malaria (1985) (2)
Even malaria parasites watch their host’s diet (2018) (2)
Immunogenic surface proteins of P. knowlesi-infected erythrocytes crossreact with antibodies against P. falciparum. (1980) (1)
Longitudinal analysis of naturally acquired antibodies to PfEMP1 CIDR domain variants and their association with malaria protection (2020) (1)
The Multilateral Initiative on Malaria: looking back and looking ahead. (2010) (1)
A platform for generating conjugated malarial vaccines to Pseudomonas aeruginosa Exoprotein A (2007) (1)
Transmission-Blocking Vaccines: From Conceptualization to Realization. (2022) (1)
On Malaria Transmission and Transmission Blocking Immunity. (2022) (1)
Discovery and disease control. (1990) (1)
Base decomposition of erythromycin A methoxime. (1996) (1)
NotThat Immunologists Still Do Malaria Knows about the Immune World Malaria Day 2009: What (2009) (1)
Block Cytoadherence Define the CD 36 Binding Region for Plasmodium falciparum-Infected Erythrocytes (1999) (1)
Malaria. Binding of infected red cells. (1989) (1)
B cell analysis of ethnic groups in Mali with differential susceptibility to malaria (2012) (1)
Surface Protein-1 Carboxyl-Terminal Fragment of Merozoite Acquired with Antibodies to the 19-kDa Passively Plasmodium yoelii Immunity to Response Involving B Cells and Th Cells in Absolute Requirement for an Active Immune (1999) (1)
The immune response in mild and severe malaria (2016) (1)
Incorporation of nucleic acid precursors by Plasmodium cynomolgi in Anopheles balabacensis. (1975) (1)
Immunologists Still Do Not Knows about the Immune System That World Malaria Day 2009: What Malaria (2009) (1)
Representational difference analysis of cDNA between two Dd2 clones of Plasmodium falciparum. (1999) (1)
Continuous in-vitro cultivation of the human malaria parasite. (1978) (0)
Crystal Structure of the DBL3x domain of the Plasmodium falcipurum VAR2CSA protein (2008) (0)
A single nucleotide polymorphism in an AP2 transcription factor encoded in the malaria-causing Plasmodium berghei alters the development of host immunity (2017) (0)
Identification of judgment network of Plasmodium falciparum erythrocyte membrane protein 1 (Pfemp1) that mediates adh board to chondroitin (2000) (0)
Search for the Sialic Acid‐Independent Receptor on Red Blood Cells for Invasion by Plasmodium falciparum (1999) (0)
The MC179 portion of the Cysteine-rich Interdomain Region (CIDR) of a Plasmodium falciparum Erythrocyte Membrane Protein-1 (PfEMP1) (2008) (0)
Crystal structure of Pf12 tandem 6-cys domains from Plasmodium falciparum (2013) (0)
Toll-like receptor 9 antagonizes antibody affinity maturation (2018) (0)
ANTI-APICAL MEMBRANE ANTIGEN 1 IGG IS MORE EFFECTIVE IN INHIBITING PLASMODIUM FALCIPARUM GROWTH AS MEASURED BY IN VITRO GROWTH INHIBITION ASSAY THAN ANTI-MEROZOITE SURFACE PROTEIN 1 42 IGG (2008) (0)
RED CELLS CD36 Peptides That Block Cytoadherence Define the CD36 Binding Region for Plasmodium falciparum-Infected Erythrocytes (1999) (0)
Implication of the Knops blood group in P-falciparum malaria and a possible role for the SL(A-) phenotype. (1997) (0)
Natural killer cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity (2018) (0)
The D o m a i n on the Duffy B l o o d Group Ant igen for B inding Plasmodium vivax and P . knowlesi Malarial Parasites to Erythrocytes (2003) (0)
Corrigendum to “Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer” [Vaccine 30 (2012) 189–194] (2013) (0)
PHASE 1 SAFETY AND IMMUNOGENICITY TRIAL OF A BLOOD-STAGE MALARIA VACCINE AMA1-C1/ISA 720 IN AUSTRALIAN ADULTS (2008) (0)
A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection (2017) (0)
Crystal structure of VAR2CSA DBL3x domain in the presence of dodecasaccharide of CSA (2008) (0)
Randomized, controlled, phase 1 study of AMA1-C1/alhydrogelo vaccine for plasmodium falciparum malaria in children in Dontgutbougou, Mali (2006) (0)
Even malaria parasites watch their host’s diet (2018) (0)
Professor Ogobara K. Doumbo (1956–June 9, 2018) (2018) (0)
The discovery of artemisinin and the Nobel Prize in Physiology or Medicine (2015) (0)
What Historical Records Teach Us about the Discovery of Quinine. (2022) (0)
Organizations (Groups); *Presidents (1997) (0)
Protein-1 in Vaccinated Volunteers Merozoite Surface Plasmodium falciparum Responses to the 42-kDa Fragment of Ex Vivo Cytokine and Memory T Cell (2008) (0)
Inhibiting the mammalian target of rapamycin as an adjunctive therapy for cerebral malaria (MPF7P.714) (2015) (0)
PARASITIZED ERYTHROCYTE BINDING TO THROMBOSPONDIN IN FALCIPARUM-MALARIA (1986) (0)
A genetic cross to identify the Plasmodium falciparium ligands for invasion of erythrocytes (1998) (0)
Using a Novel Flow Cytometry Assay falciparum Erythrocyte Membrane Protein 1 Inhibitory Antibodies of the Plasmodium (2013) (0)
Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum : Immunodominant T-cell domains map to the polymorphic regions of the molecule ( malaria / vaccines ) (2003) (0)
Characterization of a novel Plasmodium Virulence Factor (2019) (0)
Cerebral Malaria Is Regulated by Host-Mediated Changes in Plasmodium Gene Expression (2022) (0)
Individuals-Specific Memory B Cells in Malaria-Naive Plasmodium falciparum Acquisition of The TLR 9 Ligand CpG Promotes the Martin and (2009) (0)
VACCINATION WITH MSP142-C1/ALHYDROGEL (R) GENERATES ANTIGEN-SPECIFIC MEMORY B CELLS IN MALARIA-NAIVE US ADULTS AND THE CPG 7909 OLIGODEOXYNUCLEOTIDE ADJUVANT ENHANCES THIS RESPONSE (2008) (0)
Molecular identification of the CR1-related blood group antigens implicated in malarial infection (2000) (0)
Localization of nucleotide sequences on ovarian polytene chromosomes of the malaria vector Anopheles gambiae using in vitro hybridization. (1990) (0)
T cell responses in volunteers vaccinated with blood-stage malarial antigens MSP-1 and AMA-1 (2006) (0)
The direct binding of Plasmodium vivax AMA1 to erythrocytes defines a RON2-independent invasion pathway. (2022) (0)
Erratum: Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: A parasite adhesion trait implicated in cerebral malaria (Proceedings of the National Academy of Sciences of the United States of America (February 15, 2000) 97, 4 (1766-1771) DOI: 10.1073/pnas.04054 (2006) (0)
Isolatesthe Importance of CR1 in Rosetting in Field Rosetting and Demonstration of falciparum Plasmodium Receptor (CR) 1 Required for Mapping of the Region of Complement (2000) (0)
AMA1-C1/alhydrogel (R) vaccine for Plasmodium falciparum malaria induces cross-reactive antibodies to a non-vaccine AMA1 allele in malian adults (2005) (0)
Robert S. Desowitz January 2, 1926–March 24, 2008 (2008) (0)
Induced by Natural Infection and Anti-Apical Membrane Antigen-1 Antibodies Comparison of Biological Activity of Human (2013) (0)
The Impact of Ken Warren’s Leadership of the Rockefeller Foundation’s Great Neglected Diseases Program on the Future of Malaria Research (2017) (0)
Biophysical and Biochemical Correlates N-Acetylneuraminic Acid Deficiency in Erythrocyte Membranes: (2013) (0)
Using magnetic resonance imaging to elucidate the mechanism of experimental cerebral malaria rescue by 6-diazo-5-oxo-norleucine (2017) (0)
Author response: The Plasmodium falciparum rhoptry protein RhopH3 plays essential roles in host cell invasion and nutrient uptake (2017) (0)
Plasmodium falciparum multi-antigen adenvirus vectored-vaccine is immunogenic in both homolgous and heterologous boost regimens in a Yucatan swine model of malaria (2005) (0)
Novel adjunctive therapies for cerebral malaria that target metabolism (2015) (0)
Contrasting Epidemiology and Genetic Variation of Plasmodium vivax Infecting Duffy Negatives across Africa. (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Louis H. Miller?

Louis H. Miller is affiliated with the following schools:

Louis H. Miller's Academic­Influence.com Rankings

Why Is Louis H. Miller Influential?

Louis H. Miller's Published Works

Published Works

What Schools Are Affiliated With Louis H. Miller?

Louis H. Miller's AcademicInfluence.com Rankings